acamprosate has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Akgün, K; Bryant, K; Crystal, S; Edelman, EJ; Fiellin, DA; Fiellin, LE; Gaither, JR; Gordon, AJ; Goulet, JL; Justice, AC; Korthuis, PT; Kraemer, KL; Marshall, BDL; McGinnis, KA; Oldfield, BJ; Williams, EC | 1 |
Chand, PK; Thirthalli, J | 1 |
1 review(s) available for acamprosate and HIV Coinfection
Article | Year |
---|---|
The implications of medication development in the treatment of substance use disorders in developing countries.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine | 2009 |
1 other study(ies) available for acamprosate and HIV Coinfection
Article | Year |
---|---|
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Naltrexone; Prevalence; Veterans | 2020 |